I-SPY2 Trial Highlights Treatment for Rare Breast Cancer… : Oncology Times
An abstract is unavailable.
Related Articles
A Closer Look at Global MGUS Disparity: One Size Does Not Fit All
Multiple myeloma disproportionately affects Black Americans, who are twice as likely to be diagnosed with it and its precursor, monoclonal gammopathy of undetermined significance (MGUS).…
Updates in CLL Treatment: 5-Year Off-Treatment Analyses From the CLL14 and MURANO Trials
This video presents the 5-year off-treatment analyses from the CLL14 and MURANO studies.
Key Learnings from Women Founders In Switzerland
Below are videos of three women entrepreneurs being interviewed by Jim Pulcrano, Professor at IMD
Sacituzumab Tirumotecan Shows Antitumor Activity in Previously Treated Endometrial, Ovarian Cancers
Sacituzumab tirumotecan monotherapy demonstrated antitumor activity with a manageable safety profile in previously treated endometrial and ovarian cancers.
Deferiprone and idiosyncrasic neutropenia: light and shadow
In this issue of Blood Advances, Badawy et al1 address the issue of neutropenia and its associated long-term infection risks in a large cohort of patients
Next Steps for Cilta-Cel and CARTITUDE-4 in Multiple Myeloma
Binod Dhakal, MD, MS, discusses some of the next steps for evaluating ciltacabtagene autoleucel in multiple myeloma and the CARTITUDE-4 trial.
Midkine links aging with breast cancer—A new predictor of cancer risk
Despite aging being one of the strongest risk factors for cancer, little is known about the biological mechanisms that promote tumor initiation. In this issue…
NCCN Issues Updated Guidance on Genetic Testing for Several Cancers
The NCCN recently updated guidelines for genetic testing in breast, ovarian, pancreatic, prostate, colorectal, endometrial, and gastric cancers.
JNCCN 360 – Breast – Digital Breast Tomosynthesis vs Digital Mammography in Breast Cancer Screening: A Decade of Data
By continuin g to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use…
AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
Overview for AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals